Clinical Trial Update: Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing ertapenem sodium to piperacillin/tazobactam for complicated intra-abdominal infections has completed, sponsored by Merck Sh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection

Drugs mentioned

• ERTAPENEM SODIUM (ertapenem sodium)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Complicated Intra-Abdominal Infections | Phase 3 | Status: COMPLETED